TY  - GEN
AU  - Yoshimura,Reiji
AU  - Hori,Hikaru
AU  - Sugita,Atsuko
AU  - Ueda,Nobuhisa
AU  - Kakihara,Shingo
AU  - Umene,Wakako
AU  - Nakano,Yuichiro
AU  - Shinkai,Koji
AU  - Mitoma,Masae
AU  - Ohta,Makiko
AU  - Shinkai,Takahiro
AU  - Nakamura,Jun
TI  - Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients
SN  - 0278-5846
PY  - 2007///0828
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antipsychotic Agents
KW  - blood
KW  - Brain-Derived Neurotrophic Factor
KW  - Catecholamines
KW  - metabolism
KW  - Chromatography, High Pressure Liquid
KW  - Female
KW  - Genotype
KW  - Humans
KW  - Immunoenzyme Techniques
KW  - Isoxazoles
KW  - Male
KW  - Methoxyhydroxyphenylglycol
KW  - Middle Aged
KW  - Norepinephrine Plasma Membrane Transport Proteins
KW  - Paliperidone Palmitate
KW  - Polymorphism, Genetic
KW  - Pyrimidines
KW  - Risperidone
KW  - Schizophrenia
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.pnpbp.2007.03.010
ER  -